Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moschos

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Genome Medicine|May 30, 2019
Prognostic value of B cells in cutaneous melanomaSara R Selitsky, Lisle E Mose, Christof C Smith, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patientsJ Kountouras, C Zavos, D Chatzopoulos, et al.
Journal of Medicinal Chemistry|February 24, 2023
Development of [<sup>18</sup>F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET AgentsXuedan Wu, Xinrui Ma, Yaofeng Zhong, et al.
Human Pathology|June 22, 2010
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissuesStergios J Moschos, Drazen M Jukic, Charalambos Athanassiou, et al.
Molecular Cancer|October 10, 2012
Importance of glycolysis and oxidative phosphorylation in advanced melanomaJonhan Ho, Michelle Barbi de Moura, Yan Lin, et al.
Investigational New Drugs|May 31, 2022
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 studyStergios J Moschos, Shahneen Sandhu, Karl D Lewis, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Pigment Cell & Melanoma Research|July 3, 2014
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic featuresNancy E Thomas, Nathaniel A Slater, Sharon N Edmiston, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Genome Medicine|May 30, 2019
Prognostic value of B cells in cutaneous melanomaSara R Selitsky, Lisle E Mose, Christof C Smith, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patientsJ Kountouras, C Zavos, D Chatzopoulos, et al.
Journal of Medicinal Chemistry|February 24, 2023
Development of [<sup>18</sup>F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET AgentsXuedan Wu, Xinrui Ma, Yaofeng Zhong, et al.
Human Pathology|June 22, 2010
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissuesStergios J Moschos, Drazen M Jukic, Charalambos Athanassiou, et al.
Molecular Cancer|October 10, 2012
Importance of glycolysis and oxidative phosphorylation in advanced melanomaJonhan Ho, Michelle Barbi de Moura, Yan Lin, et al.
Investigational New Drugs|May 31, 2022
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 studyStergios J Moschos, Shahneen Sandhu, Karl D Lewis, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Pigment Cell & Melanoma Research|July 3, 2014
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic featuresNancy E Thomas, Nathaniel A Slater, Sharon N Edmiston, et al.
Pageof 9